Physician profile
John A Boskind
NPI 1710943519
$25,209.84
in general payments reported to CMS, 2019-2025
39 companies · $752 in 2025
The $752 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,934 · 2020: $89.13 · 2021: $309 · 2022: $1,040 · 2023: $517 · 2024: $21K · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $20K · Food and Beverage: $1,746 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $19,904.00 |
| Food and Beverage | $1,745.88 |
| Education | $188.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $19,917.41 | 2023-2024 | |
| Intuitive Surgical, INC. | $2,812.60 | 2019-2024 | Da Vinci Surgical System |
| Tela Bio, INC. | $346.28 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medtronic, INC. | $313.07 | 2021-2024 | V-Loc 180, Progrip, Endurant Iis |
| Endogastric Solutions, INC | $276.09 | 2021-2023 | Esophyx |
| Stryker Corporation | $270.52 | 2022-2025 | 1788, Aequalis Ascend Flex |
| Smith+Nephew, INC. | $120.05 | 2023-2025 | Grafix, Grafix Pl, Collagenase Santyl |
| Boston Scientific Corporation | $103.38 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Avita Medical Americas, LLC | $91.08 | 2024-2025 | Permeaderm, Cohealyx, Recell |
| Polynovo North America LLC | $90.25 | 2023-2024 | Novosorb Btm |
| Solventum Corporation | $82.91 | 2025 | Activ.A.C., V.A.C.Instill |
| Davol INC. | $68.89 | 2022-2025 | Phasix Mesh |
| Abbott Laboratories | $53.30 | 2022-2024 | Proclaim |
| Conmed Corporation | $52.32 | 2019-2020 | |
| Kerecis Limited | $45.21 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $42.46 | 2021-2025 | Endopath, Harmonic |
| Shockwave Medical, INC | $40.96 | 2021-2022 | |
| Bolton Medical INC | $36.79 | 2021-2025 | Treo Abdominal Stent-Graft System |
| Lemaitre Vascular, INC. | $33.94 | 2019 | |
| Organogenesis INC. | $32.71 | 2022 | |
| Lifenet Health | $31.55 | 2025 | Theragenesis Wound Matrix |
| Osiris Therapeutics INC. | $28.18 | 2019 | |
| Nevro Corp. | $25.19 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $24.72 | 2025 | Exparel |
| Hologic Sales and Service, LLC | $24.38 | 2023 | Coolseal Generator |
| Olympus America INC. | $23.03 | 2020-2021 | |
| W. L. Gore & Associates, INC. | $22.17 | 2024 | Gore Synecor Biomaterial |
| Neuros Medical, INC. | $21.94 | 2025 | Altius |
| Takeda Pharmaceuticals U.S.A., INC. | $21.38 | 2021 | |
| Angiodynamics, INC. | $18.99 | 2023 | Auryon Laser System 100-120 Vac |
| Ambu INC. | $17.62 | 2022 | |
| Arthrosurface Incorporated | $17.24 | 2020 | |
| Cook Medical LLC | $16.33 | 2020 | |
| Paratek Pharmaceuticals, INC. | $16.05 | 2023 | Nuzyra |
| Abbvie INC. | $15.40 | 2024 | |
| Microline Surgical INC | $14.31 | 2025 | |
| Axogen | $14.11 | 2019 | |
| Integra Lifesciences Corporation | $13.93 | 2022 | |
| Acera Surgical, INC. | $13.10 | 2023 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Boskind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.